期刊文献+

实验性癌性恶病质的发生及其干预 被引量:2

The occurrence and therapy of expremental cancer cachexia
下载PDF
导出
摘要 目的初步探讨促炎细胞因子IL-6、TNF-α在癌性恶病质(CC)形成中的作用并观察不同剂量吲哚美辛(indomethaein,IN)对CC改善效果。方法将鼠结肠腺癌26(colon26)细胞株皮下接种于BALB/c小鼠,构建CC模型。将68只BALB/c小鼠随机分成5组:健康对照组、恶病质+等渗盐水对照组、恶病质+IN 0.5mg/(kg·d)组、恶病质+IN 1.0mg/(kg·d)组、恶病质+IN 2.0mg/(kg·d)组。监测各组小鼠一般情况、去瘤体重、血清IL-6、TNF-α的水平、各生化指标浓度变化、肿瘤组织中bcl-2的表达及癌细胞的凋亡和增殖等情况。结果恶病质小鼠去瘤体重明显下降(P<0.05),血清各生化指标不同程度的出现代谢消耗状态(P<0.05),血清IL-6,TNF-α水平明显升高(P<0.05),小鼠生存时间明显缩短(P<0.05)。IN中低剂量组尤其中剂量组IL-6、TNF-α水平显著降低(P<0.05),各生化指标亦有不同程度的改善(P<0.05),但IN高剂量组较对照组指标比较无统计学意义(P>0.05)。结论炎性细胞因子IL-6、TNF-α与CC的发生密切相关,适当剂量吲哚美辛有显著的逆转CC作用。 Objective To investigate the relationship between cytokine interleukin -6 (IL -6), tumor necrosis factor-α (TNF -α) and experimental cancer cachexia as well as to observe the effect of indomethacin (IN) on the cachecitic mice. Methods Mice bearing colonic adenocarcinoma cells (colon26) were served as a model of cancer cachexia. Totally 68 healthy BALB/c mice were randomized into 5 groups: healthy control group (HC), cancer cachexia with normal saline group (CC), cancer cachexia with IN (0.5mg·kg^-1 · d^-1) group (IN1), cancer cachexia with IN (1.0mg · kg^-1 · d^-1) group (IN2), and cancer cachexia with IN (2.0mg · kg^-1 · d^-1 ) group ( IN3 ). Physiological conditions and bodyweight were documented. Biochemical indicators, serum IL - 6, and TNF - α levels were evaluated. The expression of bcl - 2 gene and the distribution of cancer cell cycle in the tumor tissues were also analyzed by flow cytometry (FLM). Results Tumor-bearing caused a wasting of non-tumor body weight degradation rate (P 〈 0. 05). Serum IL-6 and TNF-α levels were significantly elevated accompanied with nutrition depletion (P 〈 0.05). The life span of CC group was sigificantly shorter than HC group ( P 〈 0. 05). The middle-and low-dose IN improved some biochemical indicators, reduced the concentration of IL-6 and TNF-α levels (P 〈 0.05), down-regulated the cancer cell cycle compared with CC group; however, IN3 group had no significant statistical difference in these indicators (P 〈 0.05). Conclusion Cell cytokine IL -6 and TNF -α are possibly associated with cancer cachexia. IN may potentially improve the condition of cancer cachexia by down-regulating cytokines levels, promoting apoptosis, and inhibiting the proliferation of cancer cell.
出处 《癌症进展》 2007年第5期492-497,共6页 Oncology Progress
关键词 癌性恶病质 IL-6 TNF—α BCL-2 细胞周期 吲哚美辛 cancer cachexia IL - 6 TNF - α bcl - 2 cell cycle Indomethacin
  • 相关文献

参考文献13

  • 1[1]MacDonald N,Easson AM,Mazurak VC,et al.Understanding and managing cancer cachexia.J Am Coll Surg,2003,197:143
  • 2周伟,江志伟,姜军,黎介寿.一种癌性恶病质动物模型的建立[J].中华实验外科杂志,2004,21(4):490-491. 被引量:22
  • 3[3]Tisdale MJ.Cachexia in cancer patients.Nature Rer Cancer,2002,2 (11):862
  • 4[4]Plata -Salaman CR.Central nervous system mechenisms contributing to the cachexia-anorexia syndrme.Nutrition,2000,16 (10):1009
  • 5[6]Inui A.Cancer anorexia-cachexia syndrome:Current issus in research and management.CA Cancer J Clin,2002,52(2):72
  • 6[7]Trudi M,McDeritt PT,Beck SA,et al.Purification and characterization of a lipid-moblizing factor associated with cachexia inducing tumors in mice and humans.Cancer Res,1995,55:1458
  • 7[8]Fetteri NR,Metuffic JC,Carroll MA,et al.Renal cox -2 cytokines and 20-hete:Tubular and vascular mechanisms.Curr Pharm Design,2004,10 (6):613
  • 8[9]Argiles JM,Almendro V,Busquets S,et al.The pharmacological treatment of cachexia.Curr Drug Targets,2004,5(3):265
  • 9[11]Zhang G,Tuc,Zhang G,et al.Indomethacin induces apoptosis and inhibits proliferatation in chronic myeloid leukemia cells.Leuk Res,2000,24 (5):385
  • 10[12]Gao J,Niwa K,Sun W,et al.Non-steroidal anti-inflamatory drugs inhibit cellular proliferation and upregulate cyclolxygenase-2 protein expression in endmotrial cancer cells.Cancer Sci,2004,95 (11):901

二级参考文献6

  • 1Stoll BA. Indomethacin in breast cancer. Lancent, 1973, 2: 384.
  • 2Panje WR. Regression of head and neck carcinoma with a prostaglandin synthesis inhibitor. Arch Otolaryngol, 1981, 107: 658-663.
  • 3Cross DS, Platt JL, Juhn SK, et al. Administration of a prostaglandin synthesis inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 1992, 118: 526-528.
  • 4Kim CD, Sung MW, Lee SJ, et al. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytoxicity against human squamous cell carcinoma of haed and neck. Anticancer Res, 1999, 19 (1A): 455-459.
  • 5Lin Z, Jian Y, Ben HP, et al. Role of BAX in the apoptotic response to anticancer agents. Science, 2000, 290: 989-992.
  • 6R. J. Schaur,H. Fellier,H. Gleispach,E. Fink,L. Kronberger. Tumor host relations[J] 1979,Journal of Cancer Research and Clinical Oncology(3):281~285

共引文献29

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部